Core Laboratories N.V.CLBNYSE
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank49
3Y CAGR-11.4%
5Y CAGR-16.5%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-11.4%/yr
vs +39.2%/yr prior
5Y CAGR
-16.5%/yr
Recent acceleration
Acceleration
-50.6pp
Decelerating
Percentile
P49
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.11% |
| Q3 2025 | 4.72% |
| Q2 2025 | 1.47% |
| Q1 2025 | 0.74% |
| Q4 2024 | 0.72% |
| Q3 2024 | 4.33% |
| Q2 2024 | 3.38% |
| Q1 2024 | 3.31% |
| Q4 2023 | -0.20% |
| Q3 2023 | 4.45% |
| Q2 2023 | 9.62% |
| Q1 2023 | 5.31% |
| Q4 2022 | 3.03% |
| Q3 2022 | -47.70% |
| Q2 2022 | 110.47% |
| Q1 2022 | 3.46% |
| Q4 2021 | -0.14% |
| Q3 2021 | 4.39% |
| Q2 2021 | 3.08% |
| Q1 2021 | 90.67% |
| Q4 2020 | 5.20% |
| Q3 2020 | 7.14% |
| Q2 2020 | -4.60% |
| Q1 2020 | -61.50% |
| Q4 2019 | -6.58% |
| Q3 2019 | 1.04% |
| Q2 2019 | 2.67% |
| Q1 2019 | 16.42% |
| Q4 2018 | -0.54% |
| Q3 2018 | 2.28% |
| Q2 2018 | 4.03% |
| Q1 2018 | 1.92% |
| Q4 2017 | -3.07% |
| Q3 2017 | 1.27% |
| Q2 2017 | -1.25% |
| Q1 2017 | -1.27% |
| Q4 2016 | -4.72% |
| Q3 2016 | -3.27% |
| Q2 2016 | 678.15% |
| Q1 2016 | -18.03% |